Bacopa Monnieri: Benefits, Evidence, and Safety

A closer look at what this traditional memory herb can and can not do, according to the research.

Track the foods that fit your goals. Track it free with Ration →

By the Ration Editorial Team · Reviewed against primary research · Updated July 13, 2026

Bacopa monnieri, also called brahmi, is a creeping herb that grows in wetlands across Asia.

It has a long history in Ayurvedic medicine as a tonic for memory and mental clarity.

Modern supplements typically use a standardized leaf extract, concentrated for compounds called bacosides, which are thought to drive many of its effects on the brain^[3].

Bacopa is thought to act on the brain through several overlapping pathways rather than a single mechanism.

• Supporting antioxidant activity in brain tissue
• Modulating neurotransmitters involved in learning, including acetylcholine and serotonin
• Increasing brain derived neurotrophic factor, or BDNF, a protein that supports neuron growth and connections^[1]
• Reducing markers of inflammation in some animal and cell studies^[3]

The BDNF connection is one of the more consistent findings across research, which is why it carries a strong evidence grade in our database.

The strongest human evidence comes from randomized controlled trials pooled into meta-analyses.

An early meta-analysis of randomized controlled trials found that Bacopa monnieri extract improved measures of memory, particularly the speed of processing new information, compared with placebo^[4].

A more recent systematic review of plant-derived nootropics placed Bacopa among the better supported herbal options for cognition, though it noted that effect sizes are generally modest^[2].

A randomized, double-blind, placebo-controlled trial in older adults found improvements in memory along with reductions in anxiety and depression scores after consistent supplementation^[6].

Newer research continues to explore Bacopa's pharmacological profile, including its antioxidant and neuroprotective properties, though many of these findings still come from animal or laboratory models rather than large human trials^[3][5].

A 2026 study adds to this growing body of work, though as with much of the literature, sample sizes remain relatively small^[1].

• ↑BDNFAHuman trials

  Research may raise BDNF · strong agreement · 6 studies

  View 5 studies on PubMed

  • Plant-derived nootropics and human cognition: A systematic review (2023)
  • Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract (2014)
  • Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial (2008)
  • Pharmacological attributes of Bacopa monnieri extract: Current updates and clinical manifestation (2022)
  • Bacopa monnieri (2012)

Taken together, the pattern across trials is fairly consistent, modest improvements in memory recall and attention, with effects that take time to appear and are not dramatic in any single study.

One of the most consistent findings across Bacopa research is that it is not fast acting.

Most trials showing benefit used continuous dosing for 8 to 12 weeks or longer before measuring cognitive outcomes^[4][6].

This slow onset fits with a mechanism centered on BDNF and neuron growth, processes that unfold over weeks rather than hours.

Bacopa is available as capsules, tablets, powders, and liquid extracts.

• Standardized extracts, often listing a percentage of bacosides, are the form used in most clinical trials
• Daily doses in research have commonly ranged from around 300 to 450 mg of extract
• Products vary widely in bacoside concentration, which makes comparing doses across brands difficult
• Extracts are typically taken with food, since Bacopa can cause stomach upset on an empty stomach

There is no universally agreed on optimal dose, and studies have used different extract standardizations, which limits direct comparisons^[3].

In the clinical trials available, Bacopa has generally been well tolerated over periods of several weeks to months.

• Gastrointestinal upset, including nausea, cramping, or diarrhea, is the most commonly reported side effect
• Dry mouth and fatigue have also been reported in some trials
• Long term safety data beyond several months of use is limited
• Safety in pregnancy, breastfeeding, and childhood has not been well established

People taking thyroid medication or drugs metabolized by the liver should be aware that Bacopa may interact with these, based on its pharmacological profile^[3].

• Adults interested in supporting memory and attention over the long term, based on trial populations studied so far
• Older adults, since several trials specifically enrolled elderly participants^[6]
• People interested in nootropic herbs backed by more than one randomized trial, unlike many trendy alternatives^[2]

Bacopa is not a fast fix for an exam tomorrow or a big presentation this week, given how slowly its effects appear in the research.

Bacopa monnieri has one of the more credible evidence bases among herbal nootropics, with multiple randomized trials and meta-analyses pointing toward modest memory benefits^[2][4].

Its effect on raising BDNF is well supported across studies and offers a plausible biological reason for these cognitive findings^[1].

Anyone considering it should expect a slow timeline, pick a standardized extract, and stay aware of possible digestive side effects.